Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) †
- PMID: 31701955
- PMCID: PMC6802461
- DOI: 10.14745/ccdr.v38i00a01
Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) †
References
-
- Merck Canada Inc. Product monograph: Gardasil® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine]. 2011 05/24.
-
- GlaxoSmithKline Inc. Product monograph: CERVARIX™ Human Papillomavirus vaccine Types 16 and 18 (recombinant, AS04 adjuvanted). 2011 04/21.
-
- National Advisory Committee on Immunization (NACI). Statement on human papillomavirus vaccine. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007. Feb;33 ACS-2:1–31. - PubMed
